4/15
12:27 pm
fsnuy
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
Low
Report
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
2/28
08:14 am
fsnuy
Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]
Neutral
Report
Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]
2/21
01:36 am
fsnuy
Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]
Low
Report
Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]
1/29
09:09 am
fsnuy
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections [Yahoo! Finance]
Low
Report
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections [Yahoo! Finance]